Dawo laga helo RedHill Biopharma oo kaalmo ka heshay FDA si loogu daweeyo Kansarka Carruurta
Daawada RedHill Biopharma ee la baadhayo, opaganib, ayaa helay magacaabid ka timid FDA oo ah cudurrada carruurta ee dhifta ah, si loo daweeyo neuroblastoma ee carruurta.
Yeruusaalem, 10 Juun, 2026 (TPS-IL) — Shirkadda RedHill Biopharma oo fadhigeedu yahay Tel Abiib ayaa ku dhawaaqday in Hay’adda Cuntada iyo Dawooyinka ee Maraykanka (FDA) ay siisay darajo cudurrada carruurta ee dhifta ah daawadeeda la baadhayo ee opaganib, si loogu daweeyo neuroblastoma, oo ah kansar si gaar ah u saameeya dhallaanka iyo carruurta yaryar. Darajada, oo lagu daray darajadeedii hore ee dawooyinka agoonta, ayaa laga yaabaa inay bixiso faa’iidooyin ay ka mid yihiin tigidhada dib-u-eegista mudnaanta leh, dhimista khidmadaha sharciyeed, iyo mudnaanta suuqa oo toddoba sano ah haddii la ansixiyo.
Shirkaddu waxay sidoo kale muujisay xog-ururin hore oo muujisay firfircooni dhiirigelin leh oo ka dhan ah kansarka.
